The Norwalk Hour

Crohn’s caused narrowing of colon

- Keith Roach, M.D. Readers may email questions to: ToYourGood­Health@med .cornell.edu or mail questions to 628 Virginia Dr., Orlando, FL 32803.

Dear Dr. Roach: I am a 77-year-old man in good health. I was diagnosed with Crohn’s disease about 15 years ago, but had no symptoms. Recently I had a colonoscop­y after blood was found in my stool. A biopsy confirmed Crohn’s disease, and a follow-up CT scan showed a stricture in the terminal ileum. My doctor prescribed Humira, but I am concerned about the possible side effects. With no symptoms, I wonder whether I really need it.

G.L.S.

Answer: Management of Crohn’s disease is complicate­d, and there is no substitute for experience­d clinical judgment, so I asked my colleague Dr. Sunanda Kane at the Mayo Clinic. She advised me that many people who say they have no symptoms “subconscio­usly changed their diet or other habits based on early satiety, bloating or a sense of fullness.”

Dr. Kane noted also that strictures can be due to inflammati­on or fibrosis. If the stricture they found was inflammato­ry, she says: “Humira is a good therapy and the risk is worth the benefits. If this is a fibrosteno­tic stricture then we recommend a low residue diet and monitoring for complicati­ons like anemia or vitamin deficienci­es. A dedicated CT enterograp­hy can discern between an inflammato­ry and fibrosteno­tic stricture. Some people have an element of both, and Humira is good for the inflammati­on portion. In this era of COVID we try to stay away from steroids and absolutely want to treat active inflammati­on, as this appears to be a risk factor for contractin­g COVID and more complicate­d infection.”

Dr. Roach writes: A recent column on the MMR vaccine misstated the conclusion­s of a paper. The lead author of this paper noted that while the currently available

COVID-19 vaccines offer the best protection right now, an MMR vaccine for people over 40 may provide some protection against COVID-19 at very low risk and cost. Further studies are ongoing to explore whether this strategy might reduce COVID-19 infections or severity, particular­ly since the specific COVID-19 vaccines may not be available to everyone for months or even years.

Newspapers in English

Newspapers from United States